Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CloudMD stock climbs after contract with major U.S. hospital system

 Trevor Abes Trevor Abes , The Market Online
0 Comments| August 23, 2023

{{labelSign}}  Favorites
{{errorMessage}}

  • CloudMD stock (TSXV:DOC) was in the green after signing a remote patient monitoring (RPM) contract with a major U.S. regional hospital system
  • The contract will expand the company’s reach across the client’s 115 healthcare providers and more than 25,000 Medicare patients
  • CloudMD Software & Services is a North American healthcare service provider combining leading-edge technology with a national network of healthcare professionals
  • The healthcare stock (TSXV:DOC) opened with a gain of 4.17 per cent trading at $0.125 per share

CloudMD stock (TSXV:DOC) was in the green after signing a remote patient monitoring (RPM) contract with a major U.S. regional hospital system.

The company will serve the client’s 115 healthcare providers and more than 25,000 Medicare patients through its proprietary HealthyLYF patient app and portal. The contract intends to enhance access to preventive care and minimize costly emergency department visits.

CloudMD’s RPM platform integrates with existing technology to monitor and manage patients with chronic diseases, including diabetes, heart disease and respiratory illnesses.

According to Grand View Research, the global RPM market was valued at US$4.4 billion in 2022 and is expected to grow at a CAGR of 18.5 per cent until 2030.

“Our team has created and refined a differentiated RPM program, and this hospital system contract is a testament to that. I am proud of the work we have accomplished and the impact we will have on patients using our technology-enabled healthcare,” Karen Adams, CEO of CloudMD, said in a statement.

“We will continue to invest in RPM and add proprietary technologies such as iCBT and our in-pilot glucose monitoring system. This is foundational for our strategy of U.S. expansion as we continue to build a pipeline of opportunities and innovate to drive health outcomes and evidenced-based treatment,” she added.

CloudMD Software & Services is a North American healthcare service provider combining leading-edge technology with a national network of healthcare professionals. The company’s workplace health and wellbeing solution, Kii, offers a personalized healthcare experience across mental, physical and occupational health. CloudMD also specializes in workplace absence management, as well as health and productivity tools.

The healthcare stock (TSXV:DOC) opened with a gain of 4.17 per cent trading at $0.125 per share.

Join the discussion: Find out what everybody’s saying about this stock on the CloudMD Software & Services Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.




{{labelSign}}  Favorites
{{errorMessage}}


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company